Molbio Diagnostics Ltd IPO was priced at ₹768–₹807 per share with an issue size of ₹940 crore. The IPO opened on Aug 10, 2026 and closed on Aug 12, 2026, with a lot size of 18 shares and a minimum investment of ₹14,526.
| Price Band | ₹768.00 - ₹807.00 per share |
| Lot Size | 18 shares |
| Min Investment | ₹14,526 |
| Total Issue Size | ₹940.00 crore |
| Shares Offered | 1,16,46,246 |
| Issue Structure | Fresh Issue + Offer for Sale |
| Issue Type | Bookbuilding IPO |
| Lead Manager(s) | Kotak Mahindra Capital Co.Ltd., IIFL Capital Services Ltd., Jefferies India Pvt.Ltd., Motilal Oswal Investment Advisors Ltd. |
| Registrar | Kfin Technologies Ltd. |
| Listing At | BSE, NSE |
Issue price ₹807 · lot size 18 shares · estimated listing price ₹963 (GMP +₹156)
| Category | Lots | Shares | Investment | Value at listing | Profit |
|---|---|---|---|---|---|
| Retail (Min) | 1 | 18 | ₹14,526 | ₹17,334 | +₹2,808 |
| Retail (Max) | 13 | 234 | ₹1,88,838 | ₹2,25,342 | +₹36,504 |
| S-HNI (Min) | 14 | 252 | ₹2,03,364 | ₹2,42,676 | +₹39,312 |
| S-HNI (UPI limit) | 34 | 612 | ₹4,93,884 | ₹5,89,356 | +₹95,472 |
| S-HNI (Max) | 68 | 1,224 | ₹9,87,768 | ₹11,78,712 | +₹1,90,944 |
| B-HNI (Min) | 69 | 1,242 | ₹10,02,294 | ₹11,96,046 | +₹1,93,752 |
| Metric | Latest Reported |
|---|---|
| Total Income | ₹1455.17 Cr |
| Profit After Tax | ₹164.14 Cr |
| Net Worth | ₹1144.68 Cr |
Promoters: Chandrasekhar Bhaskaran Nair
| Promoter Holding (Pre-Issue) | 46.65% |
| Promoter Holding (Post-Issue) | 43.01% |
Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases.
Developed proprietary 'Truenat' platform for rapid diagnostics.
| Founded | 2000-10-01 |
| Headquarters | Verna, Salcete, South Goa, Goa, 403722 |
| Industry | Molecular Diagnostics |
| Website | https://www.molbiodiagnostics.com/ |
| Registrar | Kfin Technologies Ltd. |
| Phone | 040-79615565 |
| [email protected] |
11 answers about Molbio Diagnostics Ltd IPO — dates, pricing, allotment and listing.
Molbio Diagnostics Ltd IPO is a bookbuilding ipo of ₹940 crore. The issue was priced at ₹768–₹807 per share, with a lot size of 18 shares. Bidding ran from Mon, 10 Aug 2026 to Wed, 12 Aug 2026, with shares listed on BSE and NSE.
The price band was ₹768–₹807 per share.
One lot was 18 shares. Bids had to be placed in multiples of 18.
A retail investor needed at least ₹14,526 – one lot of 18 shares at ₹807, the upper end of the price band.
Molbio Diagnostics Ltd IPO opened on Mon, 10 Aug 2026 and closed on Wed, 12 Aug 2026.
Allotment was finalised on Thu, 13 Aug 2026.
Molbio Diagnostics Ltd shares were listed on Mon, 17 Aug 2026 on BSE and NSE.
The company intended to use the net proceeds towards funding capital expenditure towards the setting up of infrastructure for research and development facility, center of excellence and connected office space and funding capital expenditure towards the purchase of certain plant, machinery and other equipment for goa unit i, goa unit ii and visakhapatnam unit.
Kotak Mahindra Capital Co.Ltd., IIFL Capital Services Ltd., Jefferies India Pvt.Ltd. and Motilal Oswal Investment Advisors Ltd. are the book running lead managers. Kfin Technologies Ltd is the registrar to the issue.
Category-wise demand from retail, NII and QIB bidders is on the Molbio Diagnostics Ltd IPO subscription page, and on the BSE and NSE websites.
From Thu, 13 Aug 2026, check the Molbio Diagnostics Ltd IPO allotment status using your PAN, application number or DP ID – also available on the registrar's website.